| Current Price | $5.01 | Mkt Cap | $544.1M |
|---|---|---|---|
| Open | $5.00 | P/E Ratio | 15.05 |
| Prev. Close | $5.01 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.98 - $5.03 | Volume | 21,844 |
| 52-Wk Range | $1.60 - $5.95 | Avg. Daily Vol. | 192,724 |
| Current Price | $5.01 | Mkt Cap | $544.1M |
|---|---|---|---|
| Open | $5.00 | P/E Ratio | 15.05 |
| Prev. Close | $5.01 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $4.98 - $5.03 | Volume | 21,844 |
| 52-Wk Range | $1.60 - $5.95 | Avg. Daily Vol. | 192,724 |
The best Bull and Bear pitches based on recency and number of recommendations.
You ever been talking to someone and go to lean on a wall that's like 3 inches further away than you thought.
Read the most recent pitches from players about MDXG.
Recs
SmartAce
(99.97)
Submitted: 12/28/2018 11:07:03 AM :
Start Price:
$1.40
NASDAQ:MDXG Score:
-67.49
You ever been talking to someone and go to lean on a wall that's like 3 inches further away than you thought.
Recs
Bigsef77
(66.68)
Submitted: 9/20/2018 4:03:52 PM :
Start Price:
$4.45
NASDAQ:MDXG Score:
-45.28
MiMedx Announces Statistically Significant Results In New Multicenter Clinical Study Of Healing Of Diabetic Foot Ulcers Using EpiFix®
PR Newswire PR Newswire•August 24, 2018
- Study Published in International Wound Journal Reported Statistically Significant Evidence of Healing Compared to Control Group
- Intent-To-Treat EpiFix Treated Patients = 70% vs Control 50%, p=0.0338
- Per-Protocol EpiFix Treated Patients = 81% vs Control 55%, p=0.0093
MARIETTA, Ga., Aug. 24, 2018 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that a new study regarding the use of EpiFix® in the treatment of diabetic foot ulcers (DFUs) has been published in the peer-reviewed journal, International Wound Journal.
The paper is entitled "A Confirmatory Study on the Efficacy of Dehydrated Human Amnion/Chorion Membrane dHACM Allograft in the Management of Diabetic Foot Ulcers: A Prospective, Multicenter, Randomized, Controlled Study of 110 Patients from 14 Wound Clinics." The paper was authored by: William Tettelbach, MD; Shawn Cazzell, DPM; Alexander M. Reyzelman, DPM; Felix Sigal, DPM; Joseph M Caporusso, DPM; and Patrick S. Agnew, DPM. The electronic publication of the article in International Wound Journal can be found
Recs
volfan84
(87.23)
Submitted: 7/19/2018 5:53:13 PM :
Start Price:
$4.13
NASDAQ:MDXG Score:
+42.79
Apparently MiMedx Group was engaged in quite a bit of fraud. Their CEO recently left, and the interim CEO brought in was previously the interim CFO for Lehman Brothers when they were going through their bankruptcy, if I'm not mistaken. Today's bump of just under 18% (on July 19th, 2018) should give a nice additional boost for me if this one does end up going bankrupt and the equity becoming worthless. I have a real-world position of Aug. 17, 2018 $2.50 puts for this as well.
Find the members with the highest scoring picks in MDXG.
soonerbear98 (< 20) Score: +118.38
The Score Leader is the player with the highest score across all their picks in MDXG.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| soonerbear98 | < 20 | 10/3/2013 |
|
5Y | $4.52 | -41.70% | +76.68% | +118.38 | 0 Comment | |
| vj507 | 50.53 | 2/10/2015 |
|
5Y | $8.24 | -68.02% | +44.98% | +113.00 | 0 Comment | |
| oldwickdave | < 20 | 2/10/2017 |
|
3M | $8.17 | -67.75% | +29.10% | +96.85 | 1 Comment | |
| sn0wf0g | < 20 | 5/29/2018 |
|
1Y | $8.29 | -68.21% | +10.94% | +79.16 | 0 Comment | |
| WasGibt | < 20 | 12/11/2018 |
|
5Y | $1.41 | +86.88% | +11.53% | +75.35 | 0 Comment | |
| OttoBismarck | 99.95 | 11/5/2018 |
|
5Y | $6.40 | -58.83% | +9.46% | +68.29 | 0 Comment | |
| zulabu | 23.33 | 10/25/2018 |
|
3M | $5.13 | -48.64% | +11.53% | +60.17 | 0 Comment | |
| wallet2061 | 72.33 | 9/10/2018 |
|
5Y | $5.49 | -52.00% | +3.28% | +55.29 | 0 Comment | |
| RyanIdaho | 97.73 | 9/14/2018 |
|
5Y | $4.95 | -46.77% | +2.46% | +49.23 | 0 Comment | |
| walt373 | 99.91 | 8/13/2018 |
|
5Y | $4.27 | -38.29% | +5.20% | +43.49 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
| Player Name | Player Rating |
Start Date |
Call | Time Frame |
Start Price |
Stock Gain |
S&P Gain |
Score | End Date | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TrackJimCramer | 86.32 | 10/20/2015 |
|
3W | $8.89 | -70.36% | +46.84% | -117.20 | 0 Comment | |
| TrackJimCramer | 86.32 | 8/10/2015 |
|
3W | $9.37 | -5.12% | -3.58% | +1.54 | 10/20/2015 @ $8.89 | 0 Comment |
| TrackJimCramer | 86.32 | 5/29/2015 |
|
3W | $10.35 | -9.47% | -0.24% | -9.23 | 8/10/2015 @ $9.37 | 0 Comment |
| TrackCanaccord | 48.58 | 12/20/2013 |
|
NS | $7.77 | -66.09% | +65.06% | -131.15 | 0 Comment |
